The schizophrenia prodrome revisited: a neurodevelopmental perspective

Area of Science:

• Neuroscience
• Psychiatry
• Developmental Psychology

Background:

• The neurodevelopmental model of schizophrenia is widely accepted but underutilized in prodromal phase research.
• Limited focus on enduring biological vulnerability and early intervention, with most prodromal studies concentrating on emerging positive symptoms.

Purpose of the Study:

• To investigate the neurodevelopmental model in the prodromal phase of schizophrenia.
• To assess the presence of an underlying vulnerability core across different stages of psychosis risk.
• To examine treatment strategies and outcomes in adolescents at clinical high risk for psychosis.

Main Methods:

• Data collected from 62 adolescents in the Recognition and Prevention (RAP) program over 3 years.
• Subjects categorized into three clinical high-risk groups based on symptom severity (negative/nonspecific, moderate attenuated positive, severe attenuated positive).
• Assessed four neurodevelopmental risk factors: cognitive deficits, affective disturbances, social isolation, and school failure.

Main Results:

• All four vulnerability domains were equally impaired across all three risk groups, indicating a consistent underlying vulnerability core.
• Adolescents with moderate attenuated positive symptoms showed good outcomes with various medications.
• Nearly half (47%) of adolescents with severe attenuated positive symptoms converted to psychosis, with medication nonadherence being a significant risk factor.

Conclusions:

• Findings support a neurodevelopmental model of schizophrenia, emphasizing an enduring vulnerability core.
• Early intervention strategies targeting this core may be neuroprotective.
• Treatment approaches need to consider symptom severity and medication adherence in high-risk adolescents.